COSM logo

COSMOS HEALTH INC

COSMNASDAQ
πŸ† #4654 by market capEarnings Apr 21US Equity
$2.81β–Ό $0.06 (βˆ’2.09%)
Market closed Β· at close
πŸ””
Track COSM
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.1%
7dβ–Ό 10.2%
14dβ–Ό 53.5%
30dβ–Ό 45.1%
ytdβ–Ό 71.3%
1yβ–Ό 79.1%
🏦Market Cap
$14M
Small Cap
πŸ“ˆRevenue Growth (YoY)
19.9%
Healthy
πŸ“ŠGross Margin
10.3%
Thin
πŸ’΅FCF Margin
-15.7%
Thin
βš–οΈP/S Ratio
0.2x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$2.65 – $2.98
52-Week Range
$2.20 – $14.36
Volume (shares)
141,346
Avg Volume (shares)
β€”
Shares Outstanding
5.0M
Next Earnings
2027-04-21

Fundamentals Snapshot

Annual Revenue
$65M
Last Q Revenue
$19M
P/E Ratio
-0.2
P/S Ratio
0.2x
EPS (TTM)
$-8.14
Dividend Yield
0.00%
Dilution (1yr)
+58.1%
COSM logo

COSMOS HEALTH INC

COSM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$65Mβ–² +19.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
12.1%β–² +52.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$17Mβ–² +6.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$9Mβ–² +4.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.5Mβ–² +58.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$19Mβ–Ό βˆ’$8M YoY
StockOtter Β· stockotter.space

About COSMOS HEALTH INC

Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026

Latest News & Updates

AccesswireΒ·Oct 22

Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway

Now live in Oceania: e-commerce subscription business operating across Australia, New Zealand and the broader Oceania region, with sales already underway Attractive markets: together, Australia and New Zealand represent

AccesswireΒ·Oct 20

Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion

Key Highlights Record revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a record 2026 outlook reaffirmed: full-year revenue expected to surpass $90 mi

AccesswireΒ·Oct 19

Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days

● Q4 2026 U.S. revenue: approximately $15 million expected, based on the Company's current growth trajectory ● Q4 2026 gross profit: approximately $10.5 million expected, at an approximately 70% gross margin ● Subscripti

AccesswireΒ·Oct 14

Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription

● 6,287 active U.S. subscriptions as of October 14, 2026, the vast majority added since mid-September as the Company accelerates investment in its U.S. platform ● 60.5% of U.S. online checkout orders included a subscript

AccesswireΒ·Oct 13

Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days

Record day: U.S. direct-to-consumer sales exceeded $92,000 on October 11, 2026, the highest single day to date $902,000 in 30 days: approximately $30,000 in average daily sales over the trailing 30-day period Acceleratin

AccesswireΒ·Oct 7

Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million

Record nine-month revenue of approximately $54.3 million - up 19%, or $8.7 million, from $45.6 million in the same period of 2025 Nine-month 2026 revenue nearly matches the whole of 2024 - when full-year revenue was $54.